Conteduca V.; Caffo O.; Fratino L.; Lo Re G.; Basso U.; D'Angelo A.; Donini M.; Verderame F.; Ratta R.; Procopio G.; Campadelli E.; Massari F.; Gasparro D.; Ermacora P.; Messina C.; Giordano M.; Alesini D.; Zagonel V.; Veccia A.; Lolli C.; Maines F.; De Giorgi U., Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients, «FUTURE ONCOLOGY», 2015, 11, pp. 2881 - 2891 [Scientific article]
Santoni M.; Massari F.; Iacovelli R.; Ciccarese C.; Verri E.; Burattini L.; Montironi R.; Nole F.; Tortora G.; Cascinu S., Inside the 2015 ASCO Genitourinary Cancers Symposium, «FUTURE ONCOLOGY», 2015, 11, pp. 1859 - 1862 [Scientific article]
Santoni M.; Massari F.; Del Re M.; Ciccarese C.; Piva F.; Principato G.; Montironi R.; Santini D.; Danesi R.; Tortora G.; Cascinu S., Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2015, 24, pp. 809 - 824 [Scientific article]
Ciccarese C.; Modena A.; Tortora G.; Massari F., Kidney cancer and 2014: Is innovation really over?, «FUTURE ONCOLOGY», 2015, 11, pp. 1437 - 1449 [Scientific article]
Massari F.; Ciccarese C.; Santoni M.; Brunelli M.; Piva F.; Modena A.; Bimbatti D.; Fantinel E.; Santini D.; Cheng L.; Cascinu S.; Montironi R.; Tortora G., Metabolic alterations in renal cell carcinoma, «CANCER TREATMENT REVIEWS», 2015, 41, pp. 767 - 776 [Scientific article]
Modena A.; Ciccarese C.; Fantinel E.; Bimbatti D.; Tortora G.; Massari F., Metastatic castration-resistant prostate cancer: Targeting the mechanisms of resistance to abiraterone acetate and enzalutamide, «EXPERT REVIEW OF ANTICANCER THERAPY», 2015, 15, pp. 1037 - 1048 [Scientific article]
Ciccarese C.; Massari F.; Santoni M.; Heng D.Y.C.; Sotte V.; Brunelli M.; Conti A.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Cascinu S.; Tortora G.; Montironi R., New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials, «CANCER TREATMENT REVIEWS», 2015, 41, pp. 614 - 622 [Scientific article]
Massari F.; Santoni M.; Ciccarese C.; Santini D.; Alfieri S.; Martignoni G.; Brunelli M.; Piva F.; Berardi R.; Montironi R.; Porta C.; Cascinu S.; Tortora G., PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises, «CANCER TREATMENT REVIEWS», 2015, 41, pp. 114 - 121 [Scientific article]
Ciccarese C.; Santoni M.; Massari F.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Conti A.; Tortora G.; Cascinu S.; Montironi R., Present and future of personalized medicine in adult genitourinary tumors, «FUTURE ONCOLOGY», 2015, 11, pp. 1381 - 1388 [Scientific article]
Buti, Sebastiano; Ciccarese, Chiara; Zanoni, Daniele; Santoni, Matteo; Modena, Alessandra; Maines, Francesca; Gilli, Annalisa; Bria, Emilio; Brunelli, Matteo; Rimanti, Anita; Cascinu, Stefano; Ardizzoni, Andrea; Tortora, Giampaolo; Massari, Francesco, Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: Where do we stand?, «FUTURE ONCOLOGY», 2015, 11, pp. 107 - 119 [Scientific article]
Iacovelli R.; Farcomeni A.; Sternberg C.N.; Carteni G.; Milella M.; Santoni M.; Cerbone L.; Di Lorenzo G.; Verzoni E.; Ortega C.; Sabbatini R.; Ricotta R.; Messina C.; Lorusso V.; Atzori F.; De Vincenzo F.; Sacco C.; Boccardo F.; Valduga F.; Massari F.; Baldazzi V.; Cinieri S.; Mosca A.; Maria Ruggeri E.; Berruti A.; Procopio G., Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma, «THE JOURNAL OF UROLOGY», 2015, 193, pp. 1905 - 1910 [Scientific article]
Santoni M.; Buti S.; Conti A.; Porta C.; Procopio G.; Sternberg C.N.; Bracarda S.; Basso U.; De Giorgi U.; Rizzo M.; Derosa L.; Ortega C.; Massari F.; Milella M.; Bersanelli M.; Cerbone L.; Muzzonigro G.; Burattini L.; Montironi R.; Santini D.; Cascinu S., Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy, «TARGETED ONCOLOGY», 2015, 10, pp. 517 - 522 [Scientific article]
Massari F.; Bria E.; Ciccarese C.; Munari E.; Modena A.; Zambonin V.; Sperduti I.; Artibani W.; Cheng L.; Martignoni G.; Tortora G.; Brunelli M., Prognostic value of beta-tubulin-3 and c-Myc in muscle invasive urothelial carcinoma of the bladder, «PLOS ONE», 2015, 10, Article number: e0127908 , pp. 0127908 - 0127920 [Scientific article]
Bria E.; Massari F.; Maines F.; Pilotto S.; Bonomi M.; Porta C.; Bracarda S.; Heng D.; Santini D.; Sperduti I.; Giannarelli D.; Cognetti F.; Tortora G.; Milella M., Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2015, 93, pp. 50 - 59 [Scientific article]
Santoni M.; Massari F.; Cascinu S., Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients, «CELLULAR & MOLECULAR IMMUNOLOGY», 2015, 12, pp. 122 - 124 [Scientific article]
